|Status : Published
|Published On : Dec, 2023
|Report Code : VRHC1276
|Industry : Healthcare
|Available Format :
|Page : 300
The Contrast Media Agent and Injector Systems Market is expected to grow rapidly, from $7.69 billion in 2023 to $9.77 billion in 2030. Contrast media injectors are devices used to regulate contrast material before diagnostic imaging techniques such as CT or MRI scans to improve image quality. Contrast media injectors incorporate features such as preset protocols and safety devices to prevent physicians from extravasating contrast fluid. Counter media injectors may reduce the risk of unfavorable outcomes caused by incorrect contrast material injection, such as the production of air emboli. Because they reduce the amount of contrast view, the injectors' contrast is significantly boosted. The contrast media agent and Injector System Market is a rapidly growing industry in medical imaging procedures, encompassing a wide range of contrast media agents and injector systems. The market is driven by technological advancements, chronic disease prevalence, and demand for accurate and early diagnosis. The market is fueled by advanced imaging technologies in hospitals, diagnostic imaging centers, and ambulatory surgical centers. Growth is observed in regions like North America, Europe, and Asia Pacific, driven by well-established healthcare infrastructure and investments in medical imaging. However, the market faces challenges such as regulatory constraints and the risk of adverse reactions to contrast media agents. Overall, the contrast media agent and injector system market presents lucrative opportunities for market players to innovate and cater to the evolving needs of the healthcare industry.
According to the WHO 2023 report sheet, strokes, and heart attacks cause four out of every five cardiovascular fatalities, and one-third of deaths occur in adults under the age of 70. Noncommunicable diseases (NCDs) cause 71% of worldwide fatalities, killing about 15 million people each year. Because of the high mortality rate, there is a great need for diagnostic methods, with less-invasive techniques gaining favor. For ultimate efficiency, companies like Bracco are creating clever syringeless injectors that utilize every drop of contrast supplied into the device. These injectors track the amount injected as well as the imaging procedure employed, transmitting data to PACS. During the projected period, technological developments in contrast to media injector technology are likely to drive the market. However, the high cost of contrast media injectors and the adverse effects of contrast agents are expected to hinder growth.
Insight by Product Type
The contrast media agent and injector system market are divided into three sections: consumables, injector systems, and accessories. Consumables include contrast medium, injector cartridges, and needles, all of which are required for medical imaging business operations. Consumables are expected to rise at the fastest CAGR due to rising demand for single-use injectors and accessories. The injector systems category includes single-head, dual-head, and syringeless injectors with advanced features including automated injection, dose management, and data storage. The accessories section includes power supplies, foot pedals, and software, and growth is expected to be moderate due to rising interest in these products. The strong growth rate in this segment can be defined as the growing demand for consumables to ensure privacy and cleanliness during diagnostic procedures.
Insight by Application
Based on application, the contrast media agent and injector system market is categorized into radiology, interventional cardiology, and interventional radiology. The radiology segment is the largest due to its increasing use in CT scans, MRI scans, and diagnostic imaging procedures. Interventional cardiology is expected to grow significantly due to its use in procedures like angioplasty and stenting, while interventional radiology is expected to grow moderately due to its use in CT-guided biopsy and MRI-guided ablation.
Insight by End-User
The contrast media agent and injector system market are categorized into hospitals, ambulatory surgery centers, and diagnostic imaging centers. Hospitals are the largest segment, driven by the increasing use of contrast media agents and injector systems for diagnostic and interventional procedures. Ambulatory surgery centers are expected to grow significantly due to the adoption of minimally invasive procedures and advanced imaging technologies. Diagnostic imaging centers are expected to grow moderately, driven by the increasing use of contrast media agents and injector systems in various procedures.
Global Contrast Media Agent and Injector System Market Report Coverage
2018 - 2023
Base Year Considered
2025 - 2030
Market Size in 2023
U.S.D. 7.69 Billion
Revenue Forecast in 2030
U.S.D. 9.77 Billion
Segments Covered in the Report
By Product Type, By Application, by End-Users
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report
North America, Europe, Asia-Pacific, Middle East, and Rest of the World
The contrast media agent and injector system market are driven by technological advancements in medical imaging techniques, rising chronic disease prevalence, and demand for diagnostic imaging procedures. Government initiatives to improve healthcare infrastructure and access quality services also contribute to market growth. The geriatric population, increased awareness among healthcare professionals and patients, and the ability of these products for accurate imaging for diagnosis and treatment planning further expand the market. These growth drivers offer opportunities for market players to innovate and cater to the evolving needs of the healthcare industry.
To operate complex and sophisticated diagnostic imaging devices, a high level of technical skill and expertise is needed. According to the US Bureau of Labor Statistics, radiology technologists are expecting a 21% increase in employment between the years 2012 and 2023. Although this is noteworthy, the shortage of specialists and radiologists remains a big concern for countries around the world.
Many contrast media injector manufacturers are focusing on developing software that can analyze real-time data to access information on injection pressure, flow rate, contrast media type, and injection speed. This information aids in the reduction of errors and the increase of efficiencies. As a result, contrast media injectors have a huge potential for market growth in the future. Power contrast injectors, MRI contrast injectors, MRI contrast media injectors, CT scan contrast media injectors, Syringeless Injectors, and syringe-free injection systems are also providing future potential.
North America is expected to take over the entire market during the forecast period, due to a growing demand for minimally invasive procedures and an increase in the prevalence of chronic diseases due to changing lifestyles. The region's largest market share is held by the United States. Europe is the second largest market, followed by Asia Pacific, which is the fastest growing due to the increasing prevalence of cancer and cardiovascular diseases. Middle East and Africa is the smallest market, but is expected to grow significantly due to the increasing prevalence of cancer and cardiovascular diseases, the adoption of advanced imaging technologies, and the growing number of hospitals and diagnostic imaging centers.
The contrast media agent and injector system market is dynamic and competitive, with top players constantly innovating and improving products and services. Competing on factors like innovation, price, and customer service.
In February 2023, Bracco Group partnered with Wellstar Health System. Through this partnership, the company conducted trials for its FDA-approved VUEWAY (gadopiclenol) injection, which is a contrast agent for use in MRI. Bayer and Wellstar Health System are collaborating on the development of VUEWAY injection, with ongoing trials expected to be completed in 2024. The partnership advances VUEWAY's development and ensures its availability to patients in need.
APOLLO RT has announced a partnership with the Arab Society of Radiology (ASR) at Arab Health 2023. The partnership will involve APOLLO RT providing its latest products and services to the ASR, while the ASR promotes APOLLO RT's services to its members. The APOLLO Vue was a popular product at the exhibition, receiving positive feedback from healthcare professionals. This partnership is a significant development for APOLLO RT, helping to expand its reach in the Middle East market. The success of APOLLO RT's participation in Arab Health 2023 has raised awareness of its products and services in the Middle East.
Recent Development by Key Players
Key Players Covered in the Report
Some of the major players operating in the global managed detection and response industry include Bayer Ag, GE Company, Bracco Imaging S.P.A., Guerbet Group, Sino Medical-Device Technology Co. Ltd., Shenzen Seacrown Electromechanical Co. Ltd., APOLLO RT Co. Ltd., Medtron AG RT Co. Ltd., Nemoto Kyorindo Co. Ltd.
The Contrast Media Agent and Injector System Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
Segments Covered in the Report
Region Covered in the Report